Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities

European Journal of Clinical Nutrition

Volumn 62, Issue 8, 2008, Pages 953-960

  Fukino, Y ^a   Ikeda, A ^b   Maruyama, K ^a,b   Aoki, N ^c   Okubo, T ^d   Iso, H ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Taiyou Kagaku Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CATECHIN; GLUCOSE; GREEN TEA EXTRACT; HEMOGLOBIN A1C; LIPID; POLYPHENOL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY FAT; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DIABETIC DIET; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DIET SUPPLEMENTATION; EARLY INTERVENTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTERVENTION STUDY; JAPAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUTRITIONAL ASSESSMENT; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ADULT; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FEMALE; FLAVONOIDS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MALE; MIDDLE AGED; PHENOLS; PLANT EXTRACTS; TEA;

EID: 49349106441     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602806     Document Type: Article

References (50)

1. Amarowicz R, Pegg RB, Bautista DA (2000). Antibacterial activity of green tea polyphenols against Escherichia coli K 12. Nahrung 44, 60-62.
2. Astrup A, Toubro S, Cannon S, Hein P, Breum L, Madsen J (1990). Caffeine: A double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am J Clin Nutr 51, 759-767.
3. Diabetes Prevention Program Research Group (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346, 393-403.
4. Dreosti IE, Wargovich MJ, Yang CS (1997). Inhibition of carcinogenesis by tea: The evidence from experimental studies. Crit Rev Food Sci Nutr 37, 761-770.
5. Erba D, Riso P, Bordoni A, Foti P, Biagi PL, Testolin G (2005). Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J Nutr Biochem 16, 144-149.
6. Fukino Y, Aoki N, Kato Y, Watanbe T, Nakamura M, Tanimizu T (1999). Green tea consumption among the elderly, nutrition and health. J Health Welfare Stats 46, 10-17. (in Japanese).
7. Fukino Y, Shimbo M, Aoki N, Okubo T, Iso H (2005). Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol 51, 335-342.
8. Hara Y, Honda M (1990). The inhibition of α-amylase by tea polyphenols. Agric Biol Chem 54, 1939-1945.
9. Hara Y, Matsuyama S, Nakamura K (1989). Anti-tumor activity of tea catechins. Nippon Eiyou Shokuryou Gakkaishi (J Jpn Soc Nutr Food Sci 42, 39-45. (in Japanese).
10. Hase T, Komine Y, Meguro S, Takeda Y, Takahashi H, Matusi Y et al. (2001). Anti-obesity effects of tea catechins in humans. J Oleo Sci 50, 599-605.
11. Honda M, Hara V (1993). Inhibition of rat small intestinal sucrase and á-glucosidase activities by tea polyphenols. Biotech Biochem 57, 123-124.
12. Imai K, Nakachi K (1995). Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 310, 693-696.
13. Imai K, Suga K, Nakachi K (1997). Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med 26, 769-775.
14. Isemura M, Suzuki Y, Satoh K, Narumi K, Motomiya M (1993). Effects of catechins on the mouse lung carcinoma cell adhesion to the endothelial cells. Cell Biol Int 17, 559-564.
15. Iso H, Date C, Wakai K, Fukui M, Tamakoshi A, T he JACC Study Group (2006). Green tea reduces diabetes risk. Ann Intern Med 144, 554-562.
16. Ito T, Sasaki R (1995). Green tea and cancer prevention. Mod Med Sci 42, 567-574. (in Japanese).
17. Iwase K, Ota I, Torii H (1970). Improvement of official chemical analysis for tea (Part 3). Tea industry technical research. Chagyo Gijutsu Kenkyu 40, 69-73. (in Japanese).
18. Japan Diabetes Society ed. (2002). Guidelines of Treatment for Diabetes 2002-2003. Bunkodo: Tokyo. (in Japanese).
19. Kajimoto O, Kajimoto Y, Yabune M, Nakamura T, Kotani K, Suzuki Y et al. (2005). Tea catechins with a galloyl moiety reduce body weight and fat. J Health Sci 51, 161-171.
20. Kashiwabara H, Inaba M, Maruno Y, Morita T, Awata T, Negishi K et al. (2000). Insulin levels during fasting and the glucose tolerance test and Homa's index predict subsequent development of hypertension. J Hypertens 18, 83-88.
21. Kawase M, Wang R, Shiomi T, Saijo R, Yagi K (2000). Antioxidative activity of (-)-epigallocatechin-3- (3″-O-methyl) gallate isolated from fresh tea leaf and preliminary results on its biological activity. Biosci Biotechnol Biochem 64, 2218-2220.
22. Kenko Eiyo Joho Kenkyukai (2005). The national health and nutrition survery in Japan. 2003. Ministry of Health, Labour and Welfare, Japan Daiichi Shuppan: Tokyo. (in Japanese).
23. Kojima S, Takakuwa K (1987). In: Komathi Y (ed.). Nutrition Survey on Relation of Nutrition and Living Environment in Japanese. Hokendojin-sha: Tokyo. (in Japanese).
24. Mabe K, Yamada M, Oguni I, Takahashi T (1999). In vitro and in vivo activities of tea catechins against Helicobacter pylori. Antimicrob Agents Chemother 43, 1788-1791.
25. Matsumoto N, Ishigaki F, Ishigaki A, Iwashina H, Hara Y (1993). Reduction of blood glucose levels by tea catechin. Biosci Biotech Biochem 57, 525-527.
26. Mclaughlin T, Abbasi F, Cheal K, Chu J, Lamendolla C, Reaven G (2003). Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139, 802-809.
27. McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY (2003). Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. Diabetes Care 26, 758-763.
28. Ministry of Health, Labour and Welfare, Japan (2004). The national survey for diabetes. Version current 1 June 2004. Internet: http://www.mhlw.go.jp/shingi/2004/03/s0318-15.html (accessed 15 January 2006) (in Japanese).
29. Miura Y, Chiba T, Miura S, Tomita I, Umegaki K, Ikeda M et al. (2000). Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipoproteins: An ex vivo study in humans. J Nutr Biochem 11, 216-222.
30. Muramatsu K (1994) ed. Science of Tea. Asakura Pres: Tokyo. (in Japanese).
31. Muramatsu K, Fukuyo M, Hara Y (1986). Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol (Tokyo) 32, 613-622.
32. Nagao T, Meguro S, Soga S, Otsuka A. Tomonobu K, Fumoto S et al. (2001). Tea catechins suppress accumulation of body fat in humans. J Oleo Sci 50, 717-728.
33. Nara N (2005). Clinical Tests Handbook for Nurses and Dietitians 3rd ed. Ishiyaku Publishers: Tokyo. (in Japanese).
34. Ohmura T, Ueda K, Kiyohara Y, Kato I, Iwamoto H, Nakayama K et al. (1993). Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: The Hisayama Study. Diabetologia 36, 1198-1203.
35. Princen HM, van Duyvenvoorde W, Buytenhek R, Blonk C, Tijburg LB, Langius JA et al. (1998). No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Thromb Vasc Biol 18, 833-841.
36. Rice-Evans C, Leake D, Bruckdorfer KR, Diplock AT (1996). Practical approaches to low density lipoprotein oxidation: Whys, where-fores and pitfalls. Free Rad Res 25, 285-311.
37. Richarda A, Dolansky MM (2002). Tea enhances insulin activity. J Agric Food Chem 50, 7182-7186.
38. Ryu OH, Lee J, Lee KW, Kim HY, Seo JA, Kim SG et al. (2006). Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract 71, 356-358.
39. Sakanaka S, Kim M, Taniguti M, Yamamoto T (1989). Antibacterial substances in Japan green tea extract against streptococcus mutants, a cariogenic bacterium. Agric Biol Chem 53, 2307-2311.
40. Science and Technology Agency (2002). Standard Tables of Food Composition in Japan. The Fifth Revised Edition. Printing Bureau, Ministry of Finance 2000: Tokyo. (in Japanese).
41. Shimizu M (2002). Health science of tea - new possibility for physiological function. In: Muramatsu K, Oguni I, Isemura M et al. (eds). Gakkai Shupan Center: Tokyo, 187-192. (in Japanese).
42. Shimizu M, Wada S, Hayashi T, Arisawa M, Ikegaya K, Ogaku S et al. (1988). Studies on hypoglycemic constituents of Japanese tea. Yakugaku Zasshi 108, 964-970. (in Japanese).
43. Spriet LL, MacLean DA, Dyck DJ, Hultman E, Cederblad G, Graham TE (1992). Caffeine ingestion and muscle metabolism during prolong exercise in humans. Am J Physiol 262, 891-898.
44. Suganuma M, Okabe S (1996). Cancer prevention by green tea. J Clin Exp Med 176, 760-761. (in Japanese).
45. The Japan Diabetes Society (2004). Evidence-based Practice Guideline for the Treatment of Diabetes in Japan. Nankodo: Tokyo. (in Japanese).
46. Tsuchida T, Itakura H, Nakamura H (2002). Reduction of body fat in humans by long-term ingestion of catechins. Prog Med 2189-2203. (in Japanese).
47. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al. (2001). Finnish diabetes prevention study group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344, 1343-1350.
48. Unno T, Tago M, Suzuki Y, Nozawa A, Sagesaka YM, Kakuda T et al. (2005). Effect of tea catechins on postprandial plasma lipid responses in human subjects. Br J Nutr 93, 543-547.
49. Walter-Law ME, Wang XL, Law BK et al. (2002). Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 277, 34933-34940.
50. Yokozawa T, Cho EJ, Hara Y, Kitani K (2000). Antioxidative activity of green tea treated with radical initiator 2, 2′-azobis(2-amidino-propane) dihydrochloride. J Agric Food Chem 48, 5068-5073.